Biotechnology - Pharmaceutical


Current filters:


Popular Filters

101 to 125 of 998 results

Teijin and Amgen join forces on autoimmune disease research


Japan's Teijin Pharma, the core company of the Teijin Group's (TSE: 3401) health care business, has entered…

AmgenBiotechnologyImmunologicalsInflammatory diseasesLicensingPharmaceuticalResearchTeijin

Cancer drug sales reps find access to oncologist most restricted


Oncology remains the most restrictive specialty for pharmaceutical sales representative access this year…

BiotechnologyMarkets & MarketingNorth AmericaOncologyPharmaceutical

Health care M&A spending grows in 2nd-qtr 2013, says Irving Levin


Health care merger and acquisition activity strengthened in the second quarter of 2013. (View full video:…

BiotechnologyMergers & AcquisitionsPharmaceutical

Adocia re-acquires exclusive rights to insulin analog from US drug major


French biotech firm Adocia (Euronext Paris: ADOC) has agreed with US pharma major Eli Lilly (NYSE: LLY)…

AdociaBiotechnologyDiabetesEli LillyLicensingPharmaceutical

Bristol-Myers partners with South Korean firm on biopharma production


US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

HAI Europe questions pharma commitment to clinical trial data transparency, claiming leaked documents suggest otherwise


Consumer advocacy Health Action International (HAI) Europe says it welcomes any initiative that grants…

BiotechnologyEuropeNorth AmericaPharmaceuticalPoliticsRegulationResearch

EU Commission investigates alleged aid to German Pharma


The European Commission revealed last week that it has opened an in-depth investigation to verify whether…


Vertex slumps as FDA delays hepatitis C trial


US drug maker Vertex Pharmaceuticals (Nasdaq: VRTX) saw its shares drop 11% to $78 a share, in after-hours…

Anti-viralsBiotechnologyNorth AmericaPharmaceuticalRegulationResearchVertexVX-135

US orphan designation for defactinib in mesothelioma


US cancer drug developer Verastem (Nasdaq: VSTM) says that its lead cancer stem cell inhibitor, VS-6063…


Strong 1st-half at Roche driven by cancer drug


Swiss drug major Roche (ROG: SIX) has posted a health set of financial results for the first half of…


European and US drugmakers commit to responsible clinical data sharing


In a joint statement issued this morning (July 24), the European Federation of Pharmaceutical Industries…

BiotechnologyEuropeNorth AmericaPharmaceuticalRegulationResearch

Quest PharmaTech sets up partnership in South Korea


Canadian cancer specialist Quest PharmaTech (TSX-V: QPT) has entered into a long term strategic relationship…

AD BiotechBiotechnologyFinancialOncologyPharmaceuticalQuest PharmaTechResearch

Galapagos and Servier celebrate late stage discovery milestone


Belgium-based Galapagos (Euronext: GLPG) has announced a late stage discovery milestone for small molecules…


Ligand enters global license deal for women's health product


Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

UK's NICE calls for more data to consider Roche drug for a type of vasculitis


UK drug watchdog the National Institute for Health and Care Excellence (NICE) has today (July 23) published…

BiotechnologyEuropeMabTheraOncologyPharmaceuticalPricingRare diseasesRegulationRoche

Bipartisan Bill exempting FDA user fees from sequestration introduced in USA


A bipartisan group of US House of Representatives Members last week introduced the FDA Safety Over Sequestration…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPolitics

Cheaper anti-cancer drug as effective as expensive disease-specific agent in treating wet AMD


An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness…


Simponi ARIA cleared by US FDA


US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Biotech subsidiary has received US Food…

Anti-Arthritics/RheumaticsBiotechnologyJanssen BiotechJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSimponi ARIA

New Zealand consults on Victrelis listing and some Pegasys amendments


New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list boceprevir…

Anti-viralsAsia-PacificBiotechnologyMerck & CoPegasysPharmaceuticalRegulationRocheVictrelis

UK's NICE recommends hepatitis C treatment for children


In draft guidance published this week, the UK's drugs watchdog the National Institute for Health and…

Anti-viralsBiotechnologyEuropeMerck & CoPegasysPharmaceuticalPricingRegulationRocheViraferonPeg

Deal between Ensemble and Alexion will target ultra-rare disorders


USA-based drug discovery firm Ensemble Therapeutics has announced the initiation of a drug discovery…

Alexion PharmaceuticalsBiotechnologyEnsemble TherapeuticsNorth AmericaPharmaceuticalRare diseasesResearch

101 to 125 of 998 results

Back to top